Effect of hyperthermia and triblock copolymeric nanoparticles as quercetin carrier on DU145 prostate cancer cells

Current Nanoscience

Volumn 8, Issue 5, 2012, Pages 690-696

  Khoei, Samideh ^a   Azarian, Maryam ^b   Khoee, Sepideh ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Clonogenicity; DNA damages; Nanoparticles; Quercetin; Triblock copolymer

Indexed keywords

CLONOGENICITY; DNA DAMAGES; DRUG DELIVERY VEHICLES; DRUG LOADED NANOPARTICLE; FORMING ABILITY; PROSTATE CANCER CELLS; PROSTATE CARCINOMA; QUERCETIN; TRIBLOCKS;

BLOCK COPOLYMERS; CELL CULTURE; DNA; DRUG DELIVERY; FLAVONOIDS; NANOPARTICLES; PHENOLS;

FATTY ACIDS;

COPOLYMER; MACROGOL 2000; PBA; QUERCETIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; GENOTOXICITY; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; MALE; NANOENCAPSULATION; PARTICLE SIZE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 84867805551     PISSN: 15734137     EISSN: 18756786     Source Type: Journal    
DOI: 10.2174/157341312802884355     Document Type: Article

References (40)

1. Kandaswami, C.; Lee, L. T.; Lee, P. P.; Hwang, J. J.; Ke, F. C.; Huang, Y. T.; Lee, M. T. The antitumor activities of flavonoids. In Vivo, 2005, 19 (5), 895-909.
2. Middleton, E., Jr.; Kandaswami, C.; Theoharides, T. C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev., 2000, 52 (4), 673-751.
3. Krogholm, K. S.; Bredsdorff, L.; Knuthsen, P.; Haraldsdottir, J.; Rasmussen, S. E. Relative bioavailability of the flavonoids quercetin, hesperetin and naringenin given simultaneously through diet. Eur. J. Clin. Nutr., 2010, 64 (4), 432-435.
4. Aalinkeel, R.; Bindukumar, B.; Reynolds, J. L.; Sykes, D. E.; Mahajan, S. D.; Chadha, K. C.; Schwartz, S. A. The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90. Prostate, 2008, 68 (16), 1773-1789.
5. Wang, R. E.; Kao, J. L.; Hilliard, C. A.; Pandita, R. K.; Roti Roti, J. L.; Hunt, C. R.; Taylor, J. S. Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives. J. Med. Chem., 2009, 52 (7), 1912-1921.
6. Khoei, S.; Fazeli, G. R.; Amerizadeh, A.; Eslimi, D.; Goliaei, B. Elimination of Enhanced Thermal Resistance of Spheroid Culture Model of Prostate Carcinoma Cell Line by Inhibitors of Hsp70 Induction. Yakhteh Med. J., 2010, 12 (1), 105-112.
7. Barras, A.; Mezzetti, A.; Richard, A.; Lazzaroni, S.; Roux, S.; Melnyk, P.; Betbeder, D.; Monfilliette-Dupont, N. Formulation and characterization of polyphenol-loaded lipid nanocapsules. Int. J. Pharm., 2009, 379 (2), 270-277.
8. Windrum, P.; Morris, T. C.; Drake, M. B.; Niederwieser, D.; Ruutu, T. Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres. Bone Marrow Transplant, 2005, 36 (7), 601-603.
9. Liu, Y.; Li, K.; Liu, B.; Feng, S. S. A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery. Biomaterials, 2010, 31 (35), 9145-9155.
10. Sahana, B.; Santra, K.; Basu, S.; Mukherjee, B. Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in vitro evaluation. Int. J. Nanomedicine, 2010, 5, 621-630.
11. Yallapu, M. M.; Gupta, B. K.; Jaggi, M.; Chauhan, S. C. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J. Colloid Interface Sci., 2010, 351 (1), 19-29.
12. Semete, B.; Booysen, L.; Lemmer, Y.; Kalombo, L.; Katata, L.; Verschoor, J.; Swai, H. S. In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems. Nanomedicine, 2010, 6 (5), 662-671.
13. He, G.; Ma, L. L.; Pan, J.; Venkatraman, S. ABA and BAB type triblock copolymers of PEG and PLA: a comparative study of drug release properties and "stealth" particle characteristics. Int. J. Pharm., 2007, 334 (1-2), 48-55.
14. Shan, X.; Liu, C.; Yuan, Y.; Xu, F.; Tao, X.; Sheng, Y.; Zhou, H. In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer. Colloids Surf B Biointerfaces, 2009, 72 (2), 303-311.
15. Zhang, Y.; Zhuo, R. X. Synthesis, characterization, and in vitro 5-Fu release behavior of poly(2,2-dimethyltrimethylene carbonate)-poly(ethylene glycol)-poly(2,2-dimethyltrimethylene carbonate) nanoparticles. J. Biomed. Mater. Res. A, 2006, 76 (4), 674-680.
16. Owens, D. E., 3rd; Peppas, N. A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm., 2006, 307 (1), 93-102.
17. Ozcan, I.; Segura-Sanchez, F.; Bouchemal, K.; Sezak, M.; Ozer, O.; Guneri, T.; Ponchel, G. Pegylation of poly(gamma-benzyl-L-glutamate) nanoparticles is efficient for avoiding mononuclear phagocyte system capture in rats. Int. J. Nanomed., 2010, 5, 1103-1111.
18. Veronese, F. M.; Pasut, G. PEGylation, successful approach to drug delivery. Drug Discov. Today, 2005, 10 (21), 1451-1458.
19. Stone, K. R.; Mickey, D. D.; Wunderli, H.; Mickey, G. H.; Paulson, D. F. Isolation of a human prostate carcinoma cell line (DU 145). Int. J. Cancer, 1978, 21 (3), 274-281.
20. Enmon, R. M., Jr.; O'Connor, K. C.; Lacks, D. J.; Schwartz, D. K.; Dotson, R. S. Dynamics of spheroid self-assembly in liquid-overlay culture of DU 145 human prostate cancer cells. Biotechnol. Bioeng., 2001, 72 (6), 579-591.
21. Yuhas, J. M.; Li, A. P.; Martinez, A. O.; Ladman, A. J. A simplified method for production and growth of multicellular tumor spheroids. Cancer Res., 1977, 37 (10), 3639-3643.
22. Khoee, S.; Hassanzadeh, S.; Goliaie, B. Effects of hydrophobic drug-polyesteric core interactions on drug loading and release properties of poly(ethylene glycol)-polyester-poly(ethylene glycol) triblock core-shell nanoparticles Nanotechnology, 2007, 18 (17), 175602.
23. Leroueil-Le Verger, M.; Fluckiger, L.; Kim, Y. I.; Hoffman, M.; Maincent, P. Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur. J. Pharm. Biopharm., 1998, 46 (2), 137-143.
24. Singh, N. P.; McCoy, M. T.; Tice, R. R.; Schneider, E. L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res., 1988, 175 (1), 184-191.
25. Chen, C. Y.; Wang, Y. F.; Huang, W. R.; Huang, Y. T. Nickel induces oxidative stress and genotoxicity in human lymphocytes. Toxicol. Appl. Pharmacol., 2003, 189 (3), 153-159.
26. Mohseni Meybodi, A.; Mozdarani, H. DNA damage in leukocytes from Fanconi anemia (FA) patients and heterozygotes induced by mitomycin C and ionizing radiation as assessed by the comet and comet-FISH assay. Iran Biomed. J., 2009, 13 (1), 1-8.
27. Atanackovic, D.; Nierhaus, A.; Neumeier, M.; Hossfeld, D. K.; Hegewisch-Becker, S. 41.8 degrees C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases. Cancer Immunol. Immunother., 2002, 51 (11-12), 603-613.
28. Takahashi, I.; Emi, Y.; Hasuda, S.; Kakeji, Y.; Maehara, Y.; Sugimachi, K. Clinical application of hyperthermia combined with anticancer drugs for the treatment of solid tumors. Surgery, 2002, 131 (1 Suppl), S78-84.
29. Pandita, T. K.; Pandita, S.; Bhaumik, S. R. Molecular parameters of hyperthermia for radiosensitization. Crit. Rev. Eukaryot. Gene. Expr., 2009, 19 (3), 235-251.
30. Walsh, D.; Grantham, J.; Zhu, X. O.; Wei Lin, J.; van Oosterum, M.; Taylor, R.; Edwards, M. The role of heat shock proteins in mammalian differentiation and development. Environ. Med., 1999, 43 (2), 79-87.
31. Basile, A.; Biziato, D.; Sherbet, G. V.; Comi, P.; Cajone, F. Hyperthermia inhibits cell proliferation and induces apoptosis: relative signaling status of P53, S100A4, and Notch in heat sensitive and resistant cell lines. J. Cell Biochem., 2008, 103 (1), 212-220.
32. Sharif-Khatibi, L.; Kariminia, A.; Khoei, S.; Goliaei, B. Hyperthermia induces differentiation without apoptosis in permissive temperatures in human erythroleukaemia cells. Int. J. Hyperthermia, 2007, 23 (8), 645-655.
33. Araujo, J. R.; Goncalves, P.; Martel, F. Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nutr. Res., 2011, 31 (2), 77-87.
34. Senthilkumar, K.; Arunkumar, R.; Elumalai, P.; Sharmila, G.; Gunadharini, D. N.; Banudevi, S.; Krishnamoorthy, G.; Benson, C. S.; Arunakaran, J. Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3). Cell Biochem. Funct., 2011, 29 (2), 87-95.
35. Dudeja, V.; Mujumdar, N.; Phillips, P.; Chugh, R.; Borja-Cacho, D.; Dawra, R. K.; Vickers, S. M.; Saluja, A. K. Heat shock protein 70 inhibits apoptosis in cancer cells through simultaneous and independent mechanisms. Gastroenterology, 2009, 136 (5), 1772-1782.
36. Asea, A.; Ara, G.; Teicher, B. A.; Stevenson, M. A.; Calderwood, S. K. Effects of the flavonoid drug quercetin on the response of human prostate tumours to hyperthermia in vitro and in vivo. Int. J. Hyperthermia, 2001, 17 (4), 347-356.
37. Larocca, L. M.; Ranelletti, F. O.; Maggiano, N.; Rutella, S.; La Barbera, E. O.; Rumi, C.; Serra, F.; Voso, M. T.; Piantelli, M.; Teofili, L.; Leone, G. Differential sensitivity of leukemic and normal hematopoietic progenitors to the killing effect of hyperthermia and quercetin used in combination: role of heat-shock protein-70. Int. J. Cancer, 1997, 73 (1), 75-83.
38. Cukierman, E.; Khan, D. R. The benefits and challenges associated with the use of drug delivery systems in cancer therapy. Biochem. Pharmacol., 2010, 80 (5), 762-770.
39. Chambers, E.; Mitragotri, S. Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes. J. Control Release, 2004, 100 (1), 111-119.
40. Wattendorf, U.; Merkle, H. P. PEGylation as a tool for the biomedical engineering of surface modified microparticles. J. Pharm. Sci., 2008, 97 (11), 4655-4669.